Massive rotator cuff tears (MRCTs) are challenging to repair completely, because of tendon retraction, fatty infiltration and muscle atrophy.[@bib1], [@bib2], [@bib3]

The superior shoulder capsule is a thin membranous structure deep to the rotator cuff.[@bib4] A recent anatomic study has shown that the superior shoulder capsule is attached to a substantial area (30%-61%) of the greater tuberosity, suggesting that the superior shoulder capsule is an important component of the glenohumeral joint.[@bib5]

Patients with irreparable rotator cuff tears have a defect in the superior capsule, which is located on the inferior surface of the supraspinatus and infraspinatus tendons.[@bib3] Biomechanically, it was found that superior capsular defects increase glenohumeral translation in all directions, particularly superiorly, suggesting that the superior capsule works not only as a spacer but also as a stabilizer in the glenohumeral joint.[@bib4]

Because irreparable rotator cuff tears include defects in the superior capsule, a repair should include a method that reduces superior migration. This was the concept behind the superior capsular reconstruction (SCR), which was pioneered by Dr. Teruhisa Mihata in Japan in 2007 using fascia lata.[@bib3] A great concern in using fascia lata autografts (FLA) as originally described by Mihata et al. is the donor-site morbidity; it was harvested through an open approach and increased the surgical time.[@bib3]

Later on, in the United States, Hirahara and Adams[@bib6] proposed the use of the human dermal allograft (HDA) as an alternative to FLA. SCR using HDA is now becoming popular, and the number is growing at an exponential rate and shows encouraging results in the short term.[@bib1], [@bib6], [@bib7]

To reduce the potential donor-site morbidity with FLA, de Campos et al.[@bib8] developed a minimally invasive FLA-harvesting technique. They reported no significant donor-site morbidity or hip dysfunction at 18 months.[@bib9]

A biomechanical cadaveric study comparing SCR using FLA with HDA for irreparable rotator cuff tears demonstrated that both FLA and HDA repairs partially restored superior translation and completely restored subacromial contact and superior glenohumeral joint force. The HDA significantly elongated by 15% during testing, whereas the FLA lengths were unchanged.[@bib10]

The purpose of our study was to review systematically the literature to compare the clinical and radiologic outcomes and retear rates of SCR using FLA versus HDA in cases of massive irreparable rotator cuff tears (MIRCTs). We hypothesized that patients undergoing SCR using FLA would have better functional outcomes and lower graft retear rates than patients undergoing SCR using HDA.

Methods {#sec1}
=======

Study Design {#sec1.1}
------------

This systematic literature review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and checklist.[@bib11] Before evaluating the results, this review was registered with the PROSPERO International Prospective Register of Systematic Reviews in accordance with recommendations from PRISMA, and the study protocol was published online at <http://www.crd.york.ac.uk/PROSPERO/>.

Search Technique {#sec1.2}
----------------

Two independent reviewers conducted a thorough literature search of the following online databases: Pub Med and Cochrane Library. The search terms used in the titles, abstracts and keywords fields included the following: massive rotator cuff tear, superior capsular reconstruction and superior capsule. The search was conducted by the 2 independent investigators separately, and the data were extracted from each relevant article. Reviews were searched from database inception to December 2018. We also searched the reference lists of the included studies for additional eligible articles, but no more articles were identified.

Eligibility Criteria {#sec1.3}
--------------------

Studies were selected and systematically reviewed according to the following criteria.

Inclusion criteria were clinical studies reporting the results of arthroscopic superior capsular reconstruction for MRCTs using FLA or HDA. We included patients with MRCTs who were of any age or gender and were involved in any physical or sports activities. The duration of postoperative follow-up had to be at least 1 year. Studies had to use 1 or more of the following scores for clinical evaluation: American Shoulder and Elbow Surgeons Score (ASES), Visual Analog Scale (VAS), Subjective Shoulder Value (SSV), or Constant Score and had to confirm retears using MRI.

Exclusion criteria were nonclinical (e.g., cadaveric, animal or biomechanical) studies, systematic reviews or meta-analyses, paprs not written in English, case reports, surgical-technique articles without reported outcomes, abstracts, editors' comments, and letters to the editor.

Data Collection and Analysis {#sec1.4}
----------------------------

The selection of studies was performed by 2 independent investigators separately. Any disagreement was resolved by an arbiter.The 2 investigators separately reviewed the abstract of each publication and then performed a close reading of all relevant articles to minimize selection bias and errors. For multiple published articles including the same patient population (i.e., duplicate patient populations), only the most recent publication was used for data extraction.

Finally, to avoid bias, the selected articles and the relative lists of references were reviewed, assessed and discussed by all the authors.

The data were extracted from relevant articles by each of 2 independent investigators working separately. Any disagreement was resolved by an arbiter (the most senior author). Data were extracted from the text, tables and figures of all included studies. Extracted data were collected in a standardized Excel data abstraction sheet. The extracted data included study population characteristics, intervention characteristics and outcomes of interest.

Quality Assessment {#sec1.5}
------------------

Each of the 2 investigators reviewed each study independently for study quality and bias according to the Methodologic Index for Nonrandomized Studies criteria, with a possible maximum score of 16 for nonrandomized studies and 24 for comparative studies.[@bib12] Scores were reported as absolute values and as the percentage of the total possible score. Any disagreement was resolved by an arbiter (the most senior third author).

Outcome Measures {#sec1.6}
----------------

The primary outcome measures were: (1) improvements in functional shoulder scores (VAS, SSV, Constant Score, ASES Shoulder Score); (2) improvements in postoperative acromiohumeral intervals; (3) assessment of the incidence of graft retear rates in both groups.

Secondary outcomes included improvements in active shoulder range of motion (elevation, abduction, external rotation).

Statistical Analysis {#sec1.7}
--------------------

Using MedCalc statistical software version 15.8 (MedCalc software, Ostend, Belgium), the continuous data were reported as ranges. Dichotomous data (retear rates) were reported as proportions. To quantify the structured review of observational data of retear proportions in the 2 groups, the meta-analytic method of Freeman-Tukey transformation (arcsine square root transformation) was used to calculate the weighted summary proportion under the random effects model. The retear-weighted proportions of both groups were plotted in 1 forest plot graph and compared using the χ^2^ test with applied Yates correction for continuity. Heterogeneity was determined by estimating the proportion of between-study inconsistencies due to actual differences among studies, rather than differences due to random error or chance, using the *I2* statistics. Because of the heterogeneity of the studies, random effects models in a meta-analytic framework were used. The study's confidence interval was adjusted at the 95% level.

Results {#sec2}
=======

Study Selection {#sec2.1}
---------------

The combined search of Pub Med and Cochrane Library yielded 343 results after duplicates were removed. We returned to the reference lists of previously published systematic reviews to find additional articles to include, but no additional articles were retrieved. After title and abstract screening, 30 studies progressed to full text review, leaving 6 for analysis ([Fig 1](#fig1){ref-type="fig"}).[@bib1]^,^[@bib8]^,^[@bib13], [@bib14], [@bib15], [@bib16] Nine technical reviews without clinical outcomes were identified by the search.[@bib6]^,^[@bib7]^,^[@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23] One study with clinical outcomes was excluded because the number of patients with each type of graft was not mentioned.[@bib24] The same authors, Mihata et al.,[@bib3]^,^[@bib15]^,^[@bib25] published 3 papers at 3 different times on the same study population. We included only the most recent study to avoid population duplication.Fig 1Summary of the literature search, screening and review.

Study Demographics {#sec2.2}
------------------

A total of 6 studies were included in this study ([Table 1](#tbl1){ref-type="table"}).[@bib1]^,^[@bib8]^,^[@bib13], [@bib14], [@bib15], [@bib16] The level of evidence of all studies was IV case series. Included studies were divided into 2 groups: the human dermal allograft group (HDA group) and the fascia lata autograft group (FLA group). The number of shoulders in the HDA group was 155, with 153 patients; in the FLA group, the number was 140 shoulders in 140 patients. One patient in the FLA group was excluded because he was lost during follow-up.Table 1Study DemographicsType of graftStudyStudy type and designLevel of evidenceJournalMINORSMean ageMean duration of follow-upAcellular dermal allograftPennington et al.[@bib13]Retrospective case series.IV*Arthroscopy*9/1659.4 years12 months (range16-28 m)Denard et al.[@bib1]Case series (multicenter, prospective)IV*Arthroscopy*10/1662. years17.7 months (range, 12-29 m)Hirahara[@bib14]Cases series (prospective)IV*The American Journal of Orthopedics*8/1661.33 years32.38 months (range,25-39 m)Fascia lata autograftMihata[@bib15]Case seriesIV*The American Journal of Sports Medicine*10/1666.2 years60 months (range,35-110 m)Lim[@bib16]Case series (retrospective)IV*Archives of Orthopaedic and Trauma Surgery*11/1665.3 years15 months\
(range 12-24 m)De Campos Azevedo et al.[@bib8]Case series\
(prospective)IV*The Orthopaedic Journal of Sports Medicine*13/1664.8 years24 months[^1]

The mean age at time of surgery for the HDA and the FLA groups was 60.49 and 65.8 years, respectively. The mean follow-up was substantially longer in the FLA group than in the HDA group: 44.6 months (range 12-110 months) and 15.2 months (range 12-39 months), respectively ([Table 1](#tbl1){ref-type="table"}).

Only 2 studies[@bib13]^,^[@bib14] in the HDA group and 2 studies in the FLA group[@bib8]^,^[@bib16] reported gender; there were 65 males and 29 females and 16 males and 37 females, respectively. Graft thickness in the FLA group was 5-8 mm. Graft thickness in the HDA group was 1-3 mm.

Risk of Bias and Quality Assessment {#sec2.3}
-----------------------------------

The mean Methodological Index for Non-Randomized Studies score for the HDA group studies was 9/16, and for the FLA studies, it was 11/16 (56% and 69%, respectively) ([Table 1](#tbl1){ref-type="table"}). The 3 studies in the HDA group may be biased by commercial conflicts of interest between the authors and the manufacturer of the acellular dermal allograft that was used in SCR in the 3 studies.

Clinical Outcome Measures {#sec2.4}
-------------------------

### ASES Scores {#sec2.4.1}

All 3 studies[@bib1]^,^[@bib13]^,^[@bib14] in the HDA group (including 155 patients) and only 2 studies[@bib15]^,^[@bib16] in the FLA group (including 119 patients) used the ASES score. In the HDA group, ASES improved from a preoperative range of 42-52 to a postoperative range of 77.5-86.5, whereas in the FLA group, it improved from a preoperative range of 35-54.4 to a postoperative range of 73.7-94.3 ([Table 2](#tbl2){ref-type="table"})*.*

VAS for Pain Score {#sec2.5}
------------------

Of the 6 included studies, 3 studies[@bib1]^,^[@bib13]^,^[@bib14] in the HDA group, including 155 patients, and 1 study[@bib16] in the FLA group, including 31 patients, used the VAS for pain. In both groups there were improvements in the VAS for pain; in the HDA group, the VAS for pain improved from a preoperative range of 4-6.25 to a postoperative range of 0.38-1.7, whereas in the FLA group, it improved from 6 preoperatively to 2.5 postoperatively ([Table 2](#tbl2){ref-type="table"}).Table 2Clinical Scores OutcomesType of graftStudyVAS pain (mean ± SD)\
Pre PostASES (mean ± SD)\
Pre PostSSV (mean ± SD)\
Pre PostConstant\
Pre PostAcellular dermal allograftPennington et al.[@bib13]4.0306 ± 2.54781.5 ± 1.2152.22 ± 19.2981.56 ± 10.21N/RN/RN/RN/RDenard et al.[@bib1]5.8 ± 2.21.7 ± 2.143.6 ± 18.677.5 ± 22.035.0 ± 19.976.3 ± 25.2N/RN/RHirahara[@bib14]6.250.3841.7586.5N/RN/RN/RN/RFascia lata autograftMihata[@bib15]N/RN/R35 (6.7-78.3)94.3 (38.3-100)N/RN/RN/RLim[@bib16]6 ± 1.22.5 ± 1.254.4 ± 17.973.7 ± 10.8N/RN/R51.7 ± 13.963.7 ± 8.1de Campos Azevedo et al.[@bib8]N/RN/R33 ± 17.470 ± 2317.5 ± 13.464.9 ± 18[^2]

Subjective Shoulder Value Score {#sec2.6}
-------------------------------

One study in the HDA group (59 shoulders)[@bib1] and 1 study in the FLA group (22 shoulders)[@bib8] reported improvement in subjective shoulder value scores (SSV) (from 76 to 35, *P* \< .001) and (from 70 to 33, *P* \< .001), respectively ([Table 2](#tbl2){ref-type="table"}).

Range of Motion {#sec2.7}
---------------

### Active Elevation {#sec2.7.1}

In the HDA group, only 2 studies reported active elevation,[@bib1]^,^[@bib13] whereas all the studies of the FLA group did. Active elevation improved from a preoperative range of 121°-130° to a postoperative range of 158°-160° in the HDA group and from a preoperative range of 74.8°-133° to a postoperative range of 130.4°-146° in the FLA group ([Table 3](#tbl3){ref-type="table"}).Table 3Range of MovementType of GraftStudyMean Active Elevation(˚)\
Pre PostActive External Rotation\
Pre PostAbduction\
Pre PostAcellular dermal allograftPennington et al.[@bib13]121 (range 10-180)160 (range 70-180)N/RN/R103 (range 15-180)159 (range 68-180)Denard et al.[@bib1]130˚ ± 48˚158˚ ± 32˚36˚ ± 18˚45˚ ± 17˚N/RN/RHirahara[@bib14]NRNRNRNRNRNRFascia lata autograftMihata[@bib15]96.5˚ (range 10-170)130.37˚\
(range 20-180)27.2˚\
(range 0-80)42.78˚\
(range 0-90)N/RLim[@bib16]133 ± 35146 ± 1828 ± 1630 ± 15N/Rde Campos Azevedo et al.[@bib8]74.8143.8 (2 yrs)13.235.653.2120.7

Active External Rotation {#sec2.8}
------------------------

In the HDA group, only 1 study evaluated active external rotation,[@bib1] whereas all the FLA group studies did. The improvement in active external rotation was from 36°-45° (59 shoulders) in the HDA group and from a preoperative range of 13°-28° to a postoperative range of 30°-43° (140 shoulders) in the FLA group ([Table 3](#tbl3){ref-type="table"}).

Active Abduction {#sec2.9}
----------------

Only 1 study evaluated the active abduction in each group.[@bib8]^,^[@bib13] The improvement in mean active abduction was from 103°-159° (88 shoulders) in the HDA group[@bib6] and from 53.2°-120.7° (22 shoulders) in the FLA group[@bib8] ([Table 3](#tbl3){ref-type="table"}).

Radiological Outcome Measures {#sec2.10}
-----------------------------

### Acromiohumeral Distance {#sec2.10.1}

All 6 studies reported improvement in postoperative acromiohumeral distance (AHD). The acromiohumeral distance improved in the HDA group from a preoperative range of 4.5 mm-7.1 mm to a postoperative range of 6.7 mm-9.7 mm, and in the FLA group, from a preoperative range of 4.44 mm-6.4 mm to a postoperative range of 6.4 mm-9.7 mm ([Fig 2](#fig2){ref-type="fig"}). Further data concerning the Hamada and Goutallier stage of the operated shoulders are referred to in [Table 4](#tbl4){ref-type="table"}.Fig 2Forest plot of mean preoperative and postoperative acromiohumeral distance of the fascia lata autograft (FLA) group and the human dermal allograft (HDA) group. The empty bullet represents the preoperative mean acromiohumeral distance (mm). The solid bullet represents the postoperative acromiohumeral distance (mm). The blue bullets represent the FLA group; the green bullets represent the HDA group. The size of the bullet represents the size of the patient population.Table 4Radiologic Outcome MeasuresType of graftStudyStage of osteoarthritis\
(Hamada classification)Preoperative Goutallier stage (fatty infiltration)Acromiohumeral distance\
pre/post\
(mean ± SD)Acellular dermal allograftPennington et al.[@bib13]No patients were determined to have severe glenohumeral arthritis or acetabularizationPreoperative stage 3 or 47.19.7Denard et al.[@bib1]31 grade 1\
16 grade 2\
9 grade 3\
1 grade 4FD-SS[†](#tbl4fndagger){ref-type="table-fn"} 0:5:9:33:10\
FD-IS[†](#tbl4fndagger){ref-type="table-fn"} 1:9:10:18:19\
FD-SSc[†](#tbl4fndagger){ref-type="table-fn"} 11:23:14:4:56.6 ± 3.0 mm6.7 ± 3.0 mmHirahara[@bib14]Mean grade 3Mean stage 3.254.5 ± 2.25 mm7.7 ± 2.08 mmFascia lata autograftMihata[@bib15]Stage 1: 17\
Stage 2: 53\
Stage 3: 16\
Stage 4a: 1\
Stage 4b: 1Stage 2: 5\
Stage 3: 34\
Stage 4: 494.44 (range 0.6-9.0)8.75 (range 2.3-15.9)Lim[@bib16]Grade 1, 2Mean for subscapularis 1.1 ± 0.7\
Supraspinatus 2.7 ± 0.6\
Infraspinatus 2.5 ± 0.75.3 ± 2.26.4 ± 2.3de Campos Azevedo et al.[@bib8]Stage 1 :13\
Stage 2: 9Cumulative grade ≥ 36.4 ± 3.37.1 ±.2.5[^3][^4]

Graft Retear Rate {#sec2.11}
-----------------

All 6 studies reported the graft retear rate as an outcome. Graft tear was assessed on the basis of postoperative MRI, which was done at a mean of 51.4 months (range 6 months-60 months ) in 140 patients in the FLA group , whereas in the HDA group, MRIs were done for only 113 patients, and the time of MRI follow-up was at 1 year in 1 study[@bib1] and was not mentioned in the other 2 studies.[@bib13]^,^[@bib14]

The retear rate ranged from 3.4%-55% in the HDA group, whereas in the FLA group, it ranged from 4.5%-29% ([Fig 3](#fig3){ref-type="fig"}).Fig 3Forest plot of proportions of retear rates of the fascia lata autograft (FLA) group and the human dermal allograft (HDA) group. The blue bullets represent the FLA group; the green bullets represent the HDA group.

The sites of graft failure were reported in 2 studies[@bib1]^,^[@bib13] of the HDA group; there were 10 failures on the humeral side, 3 intrasubstance and 1 on the glenoid side. In the FLA group, only Lim et al.[@bib16] mentioned the graft failure site and all were on the humeral side.

Discussion {#sec3}
==========

This review demonstrates that arthroscopic SCR for MIRCTs using both FLA and HDA leads to improvement in clinical and radiologic outcomes.

There was greater improvement in the FLA group than in the HDA group in terms of range of movement. Postoperative active external rotation improved by 9° ± 1 in the HDA group and 15°-17° (range 30°-43°) in the FLA group .Postoperative active abduction improved by 56° and 67.5° in the HDA group and the FLA group, respectively. Postoperative active elevation improved by 30°-37° (range 158°-160°) and 13°-55.6° (range 130.4-146) in the HDA group and the FLA group, respectively.

There was demonstrable improvement in the VAS pain score and ASES in both groups. The improvement in the VAS pain score was greater in the HDA group, whereas the improvement in the ASES score was greater in the FLA group. One study of the HDA group[@bib1] and 1 study of the FLA group[@bib8] showed statistically significant improvement in SSV (*P* value \< .001).

The AHD is an important prognostic radiographic marker after rotator cuff repair because it signifies improvement of shoulder joint biomechanics and rotator cuff function.[@bib26] In addition, it was found that if there is no improvement or even little improvement of AHD immediately postoperatively after arthroscopic SCR, it was associated with poor survival of the graft and increased incidence of retearing.[@bib24] Lee et al. reported that the mean AHD was significantly higher in patients with graft thickness ≥ 6 mm than that in patients with graft thickness \< 6 mm.[@bib24] In this study, there was improvement of postoperative AHD in both groups, with a tendency toward better improvement in the FLA group.

Although we could not assess its statistical significance, the graft retear rate percent range in the HDA group was higher than that in the FLA group: 3.4%-55% and 4.5%-29%, respectively. There was substantial heterogeneity between the study results in each group. This demonstrated substantial heterogeneity could be explained by between-study variations in the baseline characteristics of patients in the HDA group because subscapularis tears requiring repair were included in 1 study[@bib1] and excluded in another.[@bib13] Also in the FLA group, there were notable differences in the experience levels of the surgeons in the various studies; procedures were performed by the pioneer of SCR procedures in 1 of them.[@bib15]

Moreover, the graft retear rate may be higher in the HDA group than reported because postoperative MRI was not done for all patients in this group and was done within 1 year postoperatively, unlike the FLA group in which the postoperative MRI was performed for all patients at a mean of 51.4 months. In both groups, the most common site of graft tear was at the greater tuberosity footprint.[@bib1]^,^[@bib13]^,^[@bib15] This may be due to the greater stresses on the graft on the humeral side during movement or to attrition of the graft due to acromiohumeral contact. The thickness of the superior shoulder capsule at the attachment of the greater tuberosity ranges from 4.4-9.1 mm.[@bib5] Mihata et al. found, in a biomechanical study, that graft thicknesses of 4 mm and 8 mm significantly decrease subacromial peak contact pressure at 0° and 30° of glenohumeral abduction, but only the 8 mm graft significantly decreased superior translation at 0° and 30° of glenohumeral abduction.[@bib27] And after biomechanical testing, the single-layer HD allograft elongated in a medial-lateral direction by approximately 15%, whereas the size of the 8 mm fascia lata allograft, which completely restored superior translation, did not significantly change after testing.[@bib10] Mihata et al. suggested both anterior and posterior side-to-side suturing when using human dermal allografts in arthroscopic SCR and claimed that this may limit the amount of medial-lateral elongation because the graft is being held in an anterior-posterior direction.[@bib10]

Denard et al. reported poor outcomes with 1 mm and 2 mm dermal allografts and recommended the use of 3 mm dermal allografts, which is currently the maximum thickness of dermal allografts commercially available.[@bib1]

In a clinical study by Mihata et al.,[@bib3] they found that postoperative clinical outcome scores improved significantly in patients with healed grafts compared to patients with graft tears or retears after SCR. Two studies in the FLA group[@bib15]^,^[@bib16] and 2 studies in the HDA group[@bib1]^,^[@bib14] reported improved clinical outcomes in patients with healed grafts compared to patients with nonhealed or retorn grafts. This finding suggest that graft healing is important for improvement of shoulder function after SCR.

Limitations {#sec3.1}
-----------

This study was limited by the quality of evidence available for assessing the improvements in function, pain and retear rates after SCR when using fascia lata allograft or dermal allograft. It was also limited by the small number of patients and studies, which are all case series level IV, and that made it difficult to do meta-analyses. Most studies did not have a minimum of 24 months of follow-up and lacked sufficient follow-up data to allow accurate comparison of results between the 2 groups.

Conclusions {#sec4}
===========

Arthroscopic SCR for massive irreparable rotator cuff tears using both fascia lata allograft and human acellular dermal allograft leads to improvement in clinical outcomes and radiologic outcomes. There is a lower retear rate with fascia lata allografts. The current literature is heterogeneous and has low levels of evidence.
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==================
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[^1]: m, months; MINORS, Methodological Index for Non-Randomized Studies.

[^2]: ASES, American Shoulder and Elbow Surgeons Score; NR, not reported; SSV, Subjective Shoulder Value; VAS, Visual Analog Scale.

[^3]: FD-IS, fatty degeneration of the infraspinatus; FD-SS, fatty degeneration of the supraspinatus; FD-SSC, fatty degeneration of the subscapularis.

[^4]: Data correspond to Goutallier grades 0, 1, 2, 3, and 4, respectively.
